1. Use of pulmonary ultrasound to predict in-hospital mortality in patients with COVID-19 infection.
- Author
-
Manzur-Sandoval D, García-Cruz E, Gopar-Nieto R, Araiza-Garaygordobil D, Maza AG, Ramírez-Lara E, Zebadua-Torres R, Barajas-Campos RL, Rascón-Sabido R, Mendoza-Copa G, Chango-Criollo EI, Ramírez-Galindo G, and Rojas-Velasco G
- Subjects
- Aged, COVID-19 mortality, Critical Care, Female, Hospitalization, Humans, Male, Middle Aged, Point-of-Care Testing, Respiration, Artificial statistics & numerical data, COVID-19 complications, Hospital Mortality, Intensive Care Units, Lung diagnostic imaging, Ultrasonography
- Abstract
Introduction: Lung ultrasound (LUS) implementation in patients with COVID-19 can help to establish the degree of pulmonary involvement, evaluate treatment response and estimate in-hospital outcome., Objective: To evaluate the application of a LUS protocol in patients with COVID-19 infection to predict in-hospital mortality., Methods: The study was carried out from April 1 to August 1, 2020 in patients with COVID-19 infection admitted to the Intensive Care Unit. Lung evaluation was carried out by physicians trained in critical care ultrasonography., Results: Most patients were males, median age was 56 years, and 59 % required mechanical ventilation. In-hospital mortality was 39.4 %, and in those with a LUS score ≥ 19, mortality was higher (50 %). The multiple logistic regression model showed that a LUS score ≥ 19 was significantly associated with mortality (hazard ratio = 2.55, p = 0.01)., Conclusions: LUS is a safe and fast clinical tool that can be applied at bedside in patients with COVID-19 infection to establish the degree of parenchymal involvement and predict mortality., (Copyright: © 2021 Permanyer.)
- Published
- 2021
- Full Text
- View/download PDF